Presage Biosciences, Inc.

Presage Biosciences, Inc. is a biotechnology company dedicated to revolutionizing cancer treatment. By utilizing their proprietary 3D tissue microarray technology, they provide significant advancements in precision medicine. Their innovative approach allows for the simultaneous delivery and assessment of multiple therapies directly within intact tumors, enabling tailored therapeutic strategies. The company's mission is to empower patients and clinicians with rich data insights that support informed decisions in cancer care, enhancing the effectiveness of treatment options. With a strong emphasis on research and development, Presage aims to contribute to improved patient outcomes and a better understanding of cancer biology.